https://www.businesswire.com/news/home/20250513753037/en/Verastem-Oncology-Reports-First-Quarter-2025-Financial-Results-and-Highlights-Recent-Business-Updates?feedref=Zd8jjkgYuzBwDixoAdXmJgT1albrG1Eq4mAeVP39211KIY8dqRJOTu36zg5ojSWrevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxYjwPpKemorG67JEVtPrh6fM-qD99V7nLhHRG_XnYInrw%3D%3D
Verastem Oncology Reports First Quarter 2025 Financial Results and Highlights Recent Business...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today a...
oncology reportsfirst quarter
https://www.prnewswire.com/news-releases/champions-oncology-reports-resignation-of-director-164923696.html
Champions Oncology Reports Resignation Of Director
/PRNewswire/ -- Champions Oncology, Inc. (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the...
oncology reportschampionsresignationdirector
https://www.businesswire.com/news/home/20211108005923/en/AVEO-Oncology-Reports-Third-Quarter-2021-Financial-Results-and-Provides-Business-Update
AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today reported financial results for the third quarter ended Se...
oncology reportsthird quarter